ATNM vs NSC · rev $35.0M vs P/E 18, rev $6.46B
Actinium Pharmaceuticals Inc (ATNM) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
ATNM currently screens at market cap $33.9M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the ATNM and NSC stock pages for the full models.
Not investment advice.